Treace Medical Q4 2025 preliminary revenue falls ~9% YoY; full year in line with guidance

TREACE MEDICAL CONCEPTS, INC.

2025-FY EPS reported -$0.93 revenue$212,690,000

Q4 2025 revenue $62.1M-$62.5M, down ~9% YoY at midpoint.
Full-year 2025 revenue $212.3M-$212.7M, ~2% YoY growth, in line with $211M-$213M guidance.
Added ~202 new active surgeons in 2025; total active surgeons ~3,337 (+6%).
Not issuing FY 2026 guidance now; will provide during Q4 earnings call on Feb 26, 2026.
CEO cites headwinds from broader economic conditions, softer consumer sentiment, product mix shift.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.